The OPTI-MIND study
18. Ribeiro AL, Rincon LG, Oliveira BG, Mota CC, Pires MT. Enhancing longevity of pacemakers through reprogramming. Underutilization and cost-effectiveness. Arq Bras Cardiol 2001;76:437 –44. 19. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Zakja E et al. Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the Quinquennium 2003 –07. Europace 2010;12:202 –9. 20. Gillis AM, Russo AM, Ellenbogen KA, Swerdlow CD, Olshansky B, Al-Khatib SM et al. HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons. Heart Rhythm 2012;9:1344 – 65. 21. Nielsen JC, Thomsen PE, Hojberg S, Moller M, Vesterlund T, Dalsgaard D et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J 2011;32:686 –96. 22. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline qrs duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932 –7. 23. Melzer C, Witte J, Reibis R, Bondke HJ, Combs W, Stangl K et al. Predictors of chronotropic incompetence in the pacemaker patient population. Europace 2006;8:70 –5. 24. Wilkoff BL, Miller RE. Exercise testing for chronotropic assessment. Cardiol Clin 1992; 10:705 –17. 25. Lamas GA, Knight JD, Sweeney MO, Mianulli M, Jorapur V, Khalighi K et al. Impact of rate-modulated pacing on quality of life and exercise capacity—evidence from the
Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm 2007;4:1125 –32. Hirsh BJ, Mignatti A, Garan AR, Uriel N, Colombo P, Sims DB et al. Effect of b-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure. Circ Heart Fail 2012;5:560 – 5. Sims DB, Mignatti A, Colombo PC, Uriel N, Garcia LI, Ehlert FA et al. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. Europace 2011;13:1459 –63. Tang AS, Roberts RS, Kerr C, Gillis AM, Green MS, Talajic M et al. Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 2001;103:3081 – 5. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013;15:1070 – 118. Levin V, Razavi M, Coll R, Coles JA Jr, Sambelashvili A. Interatrial conduction correlates with optimal atrioventricular timing in cardiac resynchronization therapy devices. Pacing Clin Electrophysiol 2011;34:443 – 9. Alings M, Vireca E, Bastian D, Wardeh AJ, Nimeth C, Tukkie R et al. Clinical use of automatic pacemaker algorithms: results of the automaticity registry. Europace 2011;13:976 –83. Koplan BA, Gilligan DM, Nguyen LS, Lau TK, Thackeray LM, Berg KC. A randomized trial of the effect of automated ventricular capture on device longevity and threshold measurement in pacemaker patients. Pacing Clin Electrophysiol 2008;31:1467 –74.
EP CASE EXPRESS
doi:10.1093/europace/eut413 Online publish-ahead-of-print 19 January 2014
Bjoern Sill*, Hermann Reichenspurner, and Tobias Deuse University Heart Center Hamburg, Cardiovascular Surgery, Martinistrasse 52, 20246 Hamburg, Germany
* Corresponding author. Tel: +49 152 22815308; fax: +49 40 7410 54931, Email: [email protected]
A 63-year-old patient developed right ventricular failure and intermittent complete heart block after an acute dissection of the right coronary artery. An emergency bypass surgery did not prevent right heart failure. Initially bridged with an extracorporeal membrane oxygenation, a HeartWarew ventricular assist device was implanted into the right ventricle. During the patient’s recovery phase, an intermittent complete atrioventricular (AV) block was observed. A dual-chamber pacemaker was implanted endovascularly. The ventricular lead was implanted into a posterolateral vein of the coronary sinus instead of the right ventricular cavity. The figure displays a fluoroscopy image during pacemaker implantation. The arrow indicates the ventricular lead. The atrial lead is implanted at the right atrial wall. Implantation of the ventricular lead into the coronary sinus prevents fatal entrapment within the cannula of the right ventricular assist device (RVAD) during or after implantation. A complete AV block after massive right ventricular infarction is commonly seen within this patient population. An implantation of an RVAD with placement of the cannula close to the apex complicates and endangers positioning of the pacemker lead. In this case, this problem was solved by utilizing the coronary sinus for implantation site. The full-length version of this report can be viewed at: http://www.escardio.org/communities/EHRA/publications/ep-case-reports/ Documents/dual-chamber-pacemaker-implantation.pdf.
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2013. For permissions please email: [email protected]
Downloaded from by guest on January 16, 2015
Dual-chamber pacemaker implantation with left ventricular pacing in a patient with a right ventricular assist device